Researchers at the University of Cambridge and start-up GlitterinTech have developed an optical sensor costing about $10 that they say delivers laboratory-level precision in a device small enough for wearable health monitors, with early tests showing accurate, noninvasive blood glucose tracking.
The new device is a miniature optical spectrometer, an instrument that analyzes light to reveal the chemical composition of substances. Traditional spectrometers are essential in medicine, manufacturing and environmental research, but shrinking them has usually meant sacrificing measurement range, resolution or accuracy. The Cambridge team says its "convolutional spectrometer" avoids that trade-off by applying a mathematical principle called the convolution theorem directly to incoming light, rather than separating light into component wavelengths or relying on complex reconstruction algorithms.
Built on a silicon nitride photonic platform with integrated electronics, the device operates across near-infrared wavelengths from 1200 to 1700 nanometres and can collect and process measurements in under a second. The team reports it continued to operate reliably between -20°C and 80°C, an unusually wide range for a miniature spectrometer.
In reported tests, the sensor achieved a 100% classification success rate identifying plastics, pharmaceuticals, coffee, flour and tea, and measured concentrations in water-based and organic solutions with accuracy of approximately 0.01%, which the researchers say exceeded commercial benchtop spectrometers in those experiments. It also measured several human biomarkers, including skin moisture, blood alcohol, blood lactate and blood glucose, and demonstrated noninvasive glucose tracking over an extended period in one participant.
"The key insight was to go back to the mathematics and ask whether there was a fundamentally cleaner way to retrieve spectra," said Dr. Chunhui Yao, a lead author. "This gives us high precision, strong noise tolerance, and very low computational overhead, all in a compact and low-cost system."
Prof. Qixiang Cheng, who led the project, said technical readiness set the work apart: the system operates "reliably across temperature extremes and real-world conditions." Prof. Richard Penty called the architecture "simple, scalable, and manufacturable."
The researchers say further testing is needed before the technology could become a practical medical product, but they envisage uses ranging from wearable hydration and glucose monitoring to food freshness checks, industrial quality control and environmental sensing.
Analysis
Why This Matters
- A $10 optical sensor small enough for wearables could shift laboratory-grade diagnostics from clinics into everyday devices, potentially offering needle-free glucose monitoring for people with diabetes.
- The same chip could be embedded cheaply across food production, manufacturing and environmental monitoring, making continuous material and quality checks practical at scale.
- If the design scales as described, it would sidestep the usual trade-off between spectrometer size and precision.
Background
Optical spectrometers work by analyzing how light interacts with substances to identify materials and measure chemical composition. They are standard tools in medicine, manufacturing, chemical testing and environmental research, but miniaturizing them has historically meant reduced measurement ranges, resolution or accuracy, leaving compact devices better at identifying substances than measuring them precisely. The Cambridge team's design instead performs a mathematical operation called convolution on the incoming light, using optical components with repeating spectral responses arranged in sequence, then recovers the spectrum with fast Fourier transforms. The approach keeps computational demands low while allowing bandwidth to be extended almost without limit and resolution to grow exponentially as more components are added.
Key Perspectives
The research team: The Cambridge and GlitterinTech researchers argue the convolution approach avoids the limitations that have held miniaturized spectrometers back, delivering precision that rivals or exceeds much larger instruments with a simple, manufacturable design, and they emphasize technical readiness, including stable operation across temperature extremes.
Medical caution: The researchers themselves stress that further testing would be needed before the technology becomes a practical medical product. The headline noninvasive glucose demonstration involved a single participant over an extended period, so clinical validation in larger, more diverse populations still lies ahead.
Skeptics: Controlled demonstrations are not the same as everyday use. Wearables face sweat, motion, varying skin types and changing ambient conditions, and the accuracy reported in laboratory-style tests will need to hold up outside the lab before regulators or clinicians could rely on the readings.
What to Watch
- Whether follow-up studies expand noninvasive glucose tracking beyond a single participant and toward clinical validation.
- GlitterinTech's progress in scaling up manufacturing of the silicon nitride platform at the promised low cost.
- Adoption in food testing and industrial quality control, the applications the team says could arrive before medical use.
